Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enanti Labs is a technology-driven life sciences company specializing in the development of innovative chemical processes for the synthesis of complex chiral molecules. Based in Hyderabad, India, the company operates as a contract research and manufacturing organization (CRO/CDMO) with a core focus on enantioselective catalysis and asymmetric synthesis. Enanti Labs provides high-purity chiral intermediates and active pharmaceutical ingredients (APIs) to the global pharmaceutical and biotechnology industries. By utilizing proprietary catalytic technologies, the company aims to reduce the cost and complexity associated with producing single-enantiomer drugs. Their expertise supports partners from early-stage process R&D through to large-scale commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enanti Labs.